Trzoss, Michael
Amplyx Pharmaceuticals (United States)
2 papers on CoChat
Most cited papers
- Verified
In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus
Shaw, K. J., Schell, W. A., Covel, J., Duboc, G., Giamberardino, C., Kapoor, M., Moloney, M., Soltow, Q. A., Tenor, J. L., Toffaletti, D. L., et al. (2018) · Antimicrobial Agents and Chemotherapy
Fungal Infections and StudiesAntifungal resistance and susceptibility
Cited by 121
- Verified
Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents
Juvvadi, P. R., Fox, D., Bobay, B. G., Hoy, M. J., Gobeil, S. M. C., Venters, R. A., Chang, Z., Lin, J. J., Averette, A. F., Cole, D. C., et al. (2019) · Nature Communications
Signaling Pathways in DiseaseAntifungal resistance and susceptibility
Cited by 116
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free